@article{APM17424,
author = {Federico L. Ampil and Gloria Caldito and Srinivas Devarakonda and Moiz Vora and Glenn Mills and Shawn Milligan},
title = {Longevity after radiotherapy of stage III lung cancer: superior vena cava obstruction is associated with early mortality},
journal = {Annals of Palliative Medicine},
volume = {7},
number = {2},
year = {2017},
keywords = {},
abstract = {Background: People with locally advanced lung cancer have a poor prognosis. Physicians are unable to accurately predict life expectancy of patients. The aims of this retrospective study were to identify the life spans of individuals after radiotherapy of stage III carcinoma of the lung and to determine whether potential prognostic factors could identify people with distinct life spans.
Methods: Between September 1981 and August 2010, 133 consecutive individuals underwent definitive or palliative radiotherapy (with or without chemotherapy) for stage IIIA/IIIB disease. Analysis of the survival data revealed that 14 patients experienced long-term survival, exceeding 36 months; 94 patients had a short-term life span (STLS), extending between 4 and 36 months, and 25 patients were in the end-of-life (EOL) period, referring to the last 3 months of life. Recognized pre-treatment clinicopathological features were tested for their impact on prognosis.
Results: The largest proportion of patients presenting with superior vena cava obstruction (SVCO) (P},
issn = {2224-5839}, url = {https://apm.amegroups.org/article/view/17424}
}